1999•MetabolismRequires access

Supplementation with vitamin B12 decreases homocysteine and methylmalonic acid but also serum folate in patients with end-stage renal disease

Jutta Dierkes, Ute Domröse, Andreas Ambrosch, Joern Schneede, Anne Berit Guttormsen, Klaus Neumann, Claus Luley

Open publisher page 70 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 70 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Methylmalonic acid, Cobalamin, Vitamin B12, Methylenetetrahydrofolate reductase, Homocysteine, Hyperhomocysteinemia, Internal medicine, Cyanocobalamin

Back to paper search Browse research topics Original source

Supplementation with vitamin B12 decreases homocysteine and methylmalonic acid but also serum folate in patients with end-stage renal disease — Research Paper | ScholarLens